NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/05/2025
Voltar para busca
Dado oficial do USPTO
K
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
24/05/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 40, 42, 44
Data de depósito
25/01/2019
Data de registro
24/03/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/03/2020
Última transação
24/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
JP
Examinador
MCMORROW, JANICE
Unidade examinadora
M60
Localização atual
TMO LAW OFFICE 115
Descrição da marca
The mark consists of two generally oval designs overlapped together and containing the letter "K".
Titulares e representantes
Titulares
KIRIN HOLDINGS KABUSHIKI KAISHA (also trading as Kirin Holdings Company, Limited)
KIRIN KABUSHIKI KAISHA (also trading as KIRIN Company, Limited)
Representantes
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of cancer or malignant tumorspainhematological disordersrenal diseaseendocrine diseasesimmunity disordersneurologicalpsychiatric and other central nervous system disorders; pharmaceutical preparations for supportive care in the treatment of cancer or malignant tumors; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; cells for medical purposes; bacteriological culture mediums for medical and veterinary purposes; cell culture mediums for medical and veterinary purposes; cell culture mediums for research and for scientific purposesonly for medical or veterinary purposes; reagent paper for medical purposes; gauze for dressings; empty capsules for pharmaceuticals; antiseptic absorbent cotton; adhesive plasters for medical purposes; bandages for dressings; lacteal flour for babies; dietary supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies adapted for medical purposes; food for babies; dietary supplements for animals
Classe 40
Custom manufacture of pharmaceuticals; extractionproduction and synthesis of pharmaceuticals for others; custom manufacture of industrial chemicals; custom manufacture of medical apparatus and medical instruments; manufacture of antibody-producing cells for others
Classe 42
Pharmaceutical research; research of chemicals; analysis of chemicals; testinginspection or research of pharmaceuticals; testinginspection or research of chemicals; testinginspection or research of cosmetics; testinginspection or research of foodstuff; providing technical advice relating to chemical research; providing technical advice relating to pharmaceutical development; providing technical advice relating to chemical development; rental of laboratory apparatus; rental of laboratory instruments
Classe 44
Providing medical information; medical examinations; preparation and dispensing of medication; dietary and nutritional guidance; veterinary services; rental of medical apparatus; rental of medical instruments
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
24/03/2025
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
30/11/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
28/11/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
23/10/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/09/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
30/07/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
30/07/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/06/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
24/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/01/2020
PUBO
PUBLISHED FOR OPPOSITION
07/01/2020
GPNX
NOTIFICATION PROCESSED BY IB
04/01/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/12/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/12/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/11/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
10/10/2019
RFNT
REFUSAL PROCESSED BY IB
22/06/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/06/2019
RFRR
REFUSAL PROCESSED BY MPU
03/06/2019
MAFR
APPLICATION FILING RECEIPT MAILED
17/05/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/05/2019
CNRT
NON-FINAL ACTION WRITTEN
14/05/2019
DOCK
ASSIGNED TO EXAMINER
13/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/05/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/05/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/04/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace K ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.